A study on sex hormones and skin immunity in HS and pregnancy
Part of Hormones & metabolism, Immune system & allergy, Skin clinical trials.
This study looks at how sex hormones affect skin immunity in people with hidradenitis suppurativa (HS) and in pregnant women. It aims to understand why the immune system behaves differently in these conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18 to 44 years old.
- Have hidradenitis suppurativa (HS) skin bumps at the places where skin samples will be taken, OR be a pregnant woman in the third trimester (between 29 and 37 weeks).
- Be covered by the French national health insurance (Assurance Maladie) and not on State Medical Aid.
- Agree to genetic testing on your skin samples.
- Not be immunocompromised, on certain medications, or unable to give consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the physical and biological (body-related) characteristics of hidradenitis suppurativa. It may help researchers understand the condition better and improve future care.
This study looks at how “stress” inside skin cells may be connected to hidradenitis suppurativa, a long-term painful skin condition with recurrent bumps and tunnels. Your participation may help researchers understand what drives the disease.
This trial tests an immune-focused treatment strategy for adults with moderate-to-severe hidradenitis suppurativa (HS), especially for cases where surgery is needed. If eligible, you may get a planned study treatment and be compared to a group without HS undergoing a related surgery.
This trial looks at a type of immune cell (MAIT cells) in people with hidradenitis suppurativa (a skin condition causing painful bumps). It aims to understand how these cells work and how they relate to treatments like adalimumab, secukinumab, or bimekizumab. You may be able to join if you have moderate-to-severe HS and are about to start one of these treatments.
This trial tests a new medicine called HB0043 for people with moderate to severe hidradenitis suppurativa (a skin condition causing painful lumps). It aims to see if the drug is safe and helps reduce symptoms.
This study looks at how skin cells work in people with hidradenitis suppurativa (HS), a condition that causes painful lumps under the skin. It aims to understand the disease better, which might lead to improved treatments in the future.
Hear when a new Skin Immunity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.